Neogen Corporation Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Neogen Corporation (NEOG) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 485.00 thousand shares for the 3-month period ending 2016-02-29, per its 10-Q filed 2016-03-31.
Discontinued › Income Statement
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2016-03-31
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-02-29 was 485.00K shares, a 8.49% decline year-over-year.
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-11-30 was 478.00K shares, a 9.13% increase year-over-year.
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-08-31 was 542.00K shares, a 5.45% increase year-over-year.
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-02-28 was 530.00K shares, a 14.52% decline year-over-year.
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 482.00K shares, a 12.84% decline from fiscal 2012.
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 553.00K shares, a 29.46% decline from fiscal 2011.
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2011 was 784.00K shares, a 17.72% increase from fiscal 2010.
- Neogen Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2010 was 666.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|---|---|---|
| 2016-02-29 | 485.00K shares 10-Q · filed 2016-03-31 | 500.00K shares 10-Q · filed 2016-03-31 | |||||
| 2015-11-30 | 478.00K shares 10-Q · filed 2016-01-08 | 509.00K shares 10-Q · filed 2016-01-08 | |||||
| 2015-08-31 | 542.00K shares 10-Q · filed 2015-09-30 | ||||||
| 2015-02-28 | 530.00K shares 10-Q · filed 2016-03-31 | 492.00K shares 10-Q · filed 2016-03-31 | |||||
| 2014-11-30 | 438.00K shares 10-Q · filed 2016-01-08 | 473.00K shares 10-Q · filed 2016-01-08 | |||||
| 2014-08-31 | 514.00K shares 10-Q · filed 2015-09-30 | ||||||
| 2014-02-28 | 620.00K shares 10-Q · filed 2015-04-01 | 678.00K shares 10-Q · filed 2015-04-01 | |||||
| 2013-11-30 | 916.00K shares 10-Q · filed 2014-12-30 | 939.00K shares 10-Q · filed 2014-12-30 | |||||
| 2013-08-31 | 858.00K shares 10-Q · filed 2014-09-30 | 572.00K shares 10-Q · filed 2013-09-30 | |||||
| 2013-05-31 | 482.00K shares 10-K · filed 2013-07-30 | ||||||
| 2013-02-28 | 762.00K shares 10-Q · filed 2014-04-04 | 508.00K shares 10-Q · filed 2013-03-28 | 756.00K shares 10-Q · filed 2014-04-04 | 504.00K shares 10-Q · filed 2013-03-28 | |||
| 2012-11-30 | 659.00K shares 10-Q · filed 2014-01-09 | 439.00K shares 10-Q · filed 2012-12-28 | 719.00K shares 10-Q · filed 2014-01-09 | 479.00K shares 10-Q · filed 2012-12-28 | |||
| 2012-08-31 | 520.00K shares 10-Q · filed 2013-09-30 | ||||||
| 2012-05-31 | 553.00K shares 10-K · filed 2013-07-30 | ||||||
| 2012-02-29 | 447.00K shares 10-Q · filed 2013-03-28 | 571.00K shares 10-Q · filed 2013-03-28 | |||||
| 2011-11-30 | 556.00K shares 10-Q · filed 2012-12-28 | 632.00K shares 10-Q · filed 2012-12-28 | |||||
| 2011-08-31 | 735.00K shares 10-Q · filed 2012-09-28 | ||||||
| 2011-05-31 | 784.00K shares 10-K · filed 2013-07-30 | ||||||
| 2011-02-28 | 785.00K shares 10-Q · filed 2012-03-30 | 797.00K shares 10-Q · filed 2012-03-30 | |||||
| 2010-11-30 | 803.00K shares 10-Q · filed 2011-12-30 | 797.00K shares 10-Q · filed 2011-12-30 | |||||
| 2010-08-31 | 767.00K shares 10-Q · filed 2011-09-30 | ||||||
| 2010-05-31 | 666.00K shares 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |